Clinical Trial Update: A Study to Evaluate Role of Inhaled Amikacin to Prevent Ventilator Associated Pneumonia in Patients With Cirrhosis [Phase 4]

View source ↗

Summary

A Phase 4 trial is evaluating inhaled amikacin to prevent ventilator-associated pneumonia in patients with cirrhosis (including hepatic encephalopathy); the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatic Encephalopathy
• Ventilator-associated Pneumonia

Drugs mentioned

• Amikacin inhalation (amikacin)

Snippet

Sponsor: Asian Institute of Gastroenterology, India | Conditions: Hepatic Encephalopathy, Cirrhosis | Phase 4 | Status: RECRUITING